CAPR vs PG · $1.62B cap vs P/E 25, rev $84.28B
Capricor Therapeutics Inc (CAPR) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CAPR currently screens at market cap $1.62B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CAPR and PG stock pages for the full models.
Not investment advice.